Topiramate in treatment of depressive and anger symptoms in female depressive patients: A randomized, double-blind, placebo-controlled study

Journal of Affective Disorders

Volumn 87, Issue 2-3, 2005, Pages 243-252

  Nickel, Cerstin ^a   Lahmann, Claas ^c   Tritt, Karin ^c   Muehlbacher, Moritz ^b   Kaplan, Patrick ^b   Kettler, Christian ^a   Krawczyk, Jakub ^b   Loew, Thomas H ^c   Rother, Wolfhardt K ^a   Nickel, Marius K ^a,b,c,d  

^a Clinic for Psychosomatic Medicine   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d Inntalklinik ^*  (Germany)

Author keywords

Ability testing; Aggression; Depressive disorders; Topiramate; Weight loss

Indexed keywords

PLACEBO; TOPIRAMATE;

ADULT; AGGRESSION; ANGER; ARTICLE; ATTENTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HAMILTON SCALE; HEADACHE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PARESTHESIA; POPULATION; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; STATE TRAIT ANXIETY INVENTORY; SUICIDE ATTEMPT; WEIGHT REDUCTION;

ADULT; ANGER; ANTICONVULSANTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; QUESTIONNAIRES; WEIGHT LOSS;

EID: 22844450426     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2005.04.003     Document Type: Article

References (39)

1. J.E. Alpert, T. Petersen, P.A. Roffi, G.I. Papakostas, R. Freed, M.M. Smith, A.R. Spector, A.A. Nierenberg, J.F. Rosenbaum, and M. Fava Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks Psychother. Psychosom. 72 2003 102 106
2. P. Azouvi, C. Jokic, N. Attal, P. Denys, S. Markabi, and B. Bussel Carbamazepine in agitation and aggressive behavior following severe closed-head injury: results of an open trail Brain Inj. 13 1999 797 804
3. F. Benazzi How could antidepressants worsen unipolar depression? Psychother. Psychosom. 72 2003 107 108
4. F. Benazzi Major depressive disorder with anger: a bipolar spectrum disorder? Psychother. Psychosom. 72 2003 300 306
5. V. Biton, K.R. Edwards, G.D. Montouris, J.C. Sackellares, C.L. Harden, and M. Kamin Topiramate titration and tolerability Ann. Pharmacother. 35 2001 173 179
6. V.P. Bozikas, P. Petrikis, A. Kourtis, P. Youlis, and A. Karavatos Treatment of acute mania with topiramate in hospitalized patients Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 1203 1206
7. R. Brickenkamp The d2 Attention Test (Test d2, Aufmerksamkeit-Belastungs- Test) 1994 Hogrefe Goettingen
8. M. Bullinger, and I. Kirchberger SF-36 Health Survey (Fragebogen zum Gesundheitszustand, SF-36) 1998 Hogrefe Goettingen
9. L.L. Carpenter, Z. Leon, S. Yasmin, and L.H. Price Do obese depressed patients respond to topiramate?: retrospective chart review J. Affect. Disord. 69 2002 251 255
10. A. Dufner, J. Jensen, and F. Schumacher Statistic with SAS 1992 Teubner Stuttgart
11. M. Fava Psychopharmacologic treatment of pathologic aggression Psychiatr. Clin. North Am. 20 1997 427 451
12. G.A. Fava Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications Psychol. Med. 29 1999 47 61
13. G.A. Fava, C. Ruini, and N. Sonino Management of recurrent depression in primary care Psychother. Psychosom. 72 2003 3 9
14. B. Fhager, I.-M. Meiri, M. Sjoegren, and A. Edman Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study Int. Psychogeriatr. 15 2003 307 309
15. I.D. Glick, S.R. Murray, P. Vasudevan, S.R. Marder, and R.J. Hu Treatment with atypical antypsychotics: new indications and new populations J. Psychiatr. Res. 35 2001 187 191
16. A. Gordon, and L.H. Price Mood stabilization and weight loss with topiramate Am. J. Psychiatry 156 1999 968 969
17. R.A. Gould, S. Ball, S.P. Kaspi, M.W. Otto, M.H. Pollack, A. Shekhar, and M. Fava Prevalence and correlates of anger attacks: a two site study J. Affect. Disord. 39 1996 31 38
18. M. Hamilton Development of a rating scale; for primary depressive illness Br. J. Soc. Clin. Psychol. 6 1967 278 296
19. E. Hollander, K.A. Tracy, A.C. Swann, E.F. Coccaro, S.L. McElroy, P. Wozniak, K.W. Sommerville, and C.B. Nemeroff Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders Neuropsychopharmacology 28 2003 1186 1197
20. D.S. Janowsky, J.E. Kraus, J. Barnhill, B. Elamir, and J.M. Davis Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study J. Clin. Psychopharmacol. 23 2003 500 504
21. I. Kusumi, K. Suzuki, Y. Sasaki, K. Kameda, and T. Koyama Treatment response in depressed patients with enhanced Ca mobilisation stimulated by serotonin Neuropsychopharmacology 23 2000 690 696
22. S. Leucht, J. McGrath, P. White, and W. Kissling Carbamazepine augmentation for schizophrenia: how good is the evidence J. Clin. Psychiatry 63 2002 218 224
23. R.S. McIntyre, D.A. Mancini, S. McCann, J. Srinivasan, D. Sagman, and S.H. Kennedy Topiramate versus buproprion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study Bipolar Disord. 4 2002 207 213
24. M. Muellner Evidence Based Medicine 2002 Springer Wien
25. M. Nickel, C. Nickel, F. Mitterlehner, K. Tritt, C. Lahmann, P. Leiberich, W. Rother, and T. Loew Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study J. Clin. Psychiatry 65 2004 1511 1519
26. M. Nickel, C. Nickel, P. Leiberich, C. Lahmann, F. Mitterlehner, P. Forthuber, K. Tritt, W. Rother, and T. Loew Psychosocial characteristics in persons who often change their psychotherapists Wien. Med. Wochenschr. 154 2004 163 169
27. M.A. Posternak, and M. Zimmerman Anger and aggression in psychiatric outpatients J. Clin. Psychiatry 63 2002 665 672
28. A.V. Ravindran, K. Matheson, J. Griffiths, Z. Merali, and H. Anisman Stress, coping, uplifts, and quality of life in subtypes of depression: a conceptual frame and emerging data J. Affect. Disord. 71 2002 121 130
29. H.C. Rubin, M.H. Rapaport, B. Levine, J.K. Gladsjo, A. Rabin, M. Auerbach, L.L. Judd, and R. Kaplan Quality of well being in panick disorder: the assessment of psychiatric and general disability J. Affect. Disord. 57 2000 217 221
30. P. Schwenkmezger, V. Hodapp, and C.D. Spielberger Das State-Trait-Aergerausdrucks-Inventar 1992 Huber Goettingen
31. P.N. Tariot, R. Erb, C.A. Podgorski, C. Cox, S. Patel, L. Jakimovich, and C. Irvine Efficacy and tolerability of carbamazepine for agitation and aggression in dementia Am. J. Psychiatry 155 1998 54 61
32. J. Tedlow, V. Leslie, B.R. Keefe, J. Alpert, A.A. Nierenberg, J.F. Rosenbaum, and M. Fava Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks J. Affect. Disord. 52 1999 217 223
33. C.J. Teter, J.J. Early, and C.M. Gibbs Treatment of affective disorder and obesity with topiramate Ann. Pharmacother. 34 2000 1262 1265
34. H.M. van Praag Anxiety and increased aggression as pacemakers of depression Acta Psychiatr. Scand. 98 suppl. 393 1998 81 88
35. E. Vieta, A. Gilabert, A. Rodriguez, A. Garcia-Castrillon, M.J. Luna, E. Arrufat, and G. Garcia-Pares Effectiveness and safety of topiramate in treatment-resistant bipolar disorder Actas Esp. Psiquiatr. 29 2001 148 152
36. E. Vieta, C. Torrent, G. Garcia-Ribas, A. Gilabert, A. Rodriguez, J. Cadevall, A. Garcia-Castrillon, P. Lusilla, E. Arrufat, and G. Garcia-Pares Use of topiramate in treatment-resistant bipolar spectrum disorders J. Clin. Psychopharmacol. 22 2002 431 435
37. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold Epilepsy Res. 28 1997 167 179
38. R. Yehuda, R.K. Yang, J.A. Golier, L. Tischler, B. Liong, and K. Decker Effect of topiramate on glucocorticoid receptor mediated action Neuropsychopharmacology 29 2004 433 439
39. U. Ziemann Pharmacology of TMS Suppl. Clin. Neurophysiol. 56 2003 226 231